Rosacea and Use of Continuous Positive Airway Pressure Mask for Obstructive Sleep Apnea Syndrome: Report of Five Cases.

Autor:	Logger JGM; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., Peppelman M; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., van Vugt R; Department of Anesthesiology, Sint Maartenskliniek, Nijmegen, The Netherlands., Driessen RJB; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Jazyk:	angličtina
Zdroj:	Annals of dermatology [Ann Dermatol] 2020 Jun; Vol. 32 (3), pp. 247-250. Date of Electronic Publication: 2020 Apr 24.
DOI:	10.5021/ad.2020.32.3.247
Abstrakt:	Rosacea is a chronic inflammatory skin disease of unknown etiology. We noticed a series of patients who were diagnosed with rosacea as well as obstructive sleep apnea syndrome (OSAS), for which they used a continuous positive airway pressure (CPAP) mask. This case series aims to give insight in the possible relationship between rosacea and the use of a CPAP mask for OSAS. We present five patients with OSAS who developed or worsened rosacea symptoms after use of a CPAP mask covering nose and mouth. Two patients showed centrofacial symptoms consistent with the shape of the CPAP mask; three patients had nasal cutaneous symptoms. It is postulated that the occlusive effect of the CPAP mask, increasing skin humidity and temperature, can induce primary symptoms in patients with an underlying sensibility for rosacea. This could have implications for choice of CPAP mask type and topical therapeutic options for rosacea. Competing Interests: CONFLICTS OF INTEREST: Jade G. M. Logger has received a research grant from Galderma. She carried out clinical trials for Abbvie, Novartis, Janssen and LEO Pharma. Rieke J. B. Driessen has received a research grant from Galderma. She carried out clinical trials for Cutanea Life Sciences, Galderma, Abbvie, Novartis and Janssen. She has received reimbursement for attending meetings from Abbvie and Galderma. She has served as a consultant for Abbvie, Galderma and Novartis. Fees were paid directly to the institution. Malou Peppelman and Roel van Vugt have no conflicts of interest to declare. (Copyright © 2020 The Korean Dermatological Association and The Korean Society for Investigative Dermatology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu